Marubi(SH:603983) Xin Lang Cai Jing·2025-10-31 02:29Core Insights - Marubi Biotechnology (603983.SH) reported its Q3 2025 results, revealing that 12 institutional investors hold a total of 28.2179 million A-shares, accounting for 7.04% of the company's total share capital [1] - The top ten institutional investors collectively hold 6.95% of the shares, with a decrease of 0.69 percentage points compared to the previous quarter [1] Institutional Holdings - The number of institutional investors holding Marubi's A-shares is 12, with a total holding of 28.2179 million shares [1] - The top ten institutional investors include various funds and banks, with the largest being Kaishi Fund and several others from major banks [1] - The proportion of shares held by the top ten institutional investors has decreased by 0.69 percentage points from the last quarter [1] Public Fund Activity - Two public funds increased their holdings, namely ICBC New Generation Consumption Mixed and ICBC Consumption Service Mixed A, with an increase ratio of 0.14% [2] - Four public funds reduced their holdings, including Fuquan Value Creation Mixed A and Fuquan Quality Life Mixed A, with a decrease ratio of 0.42% [2] - One new public fund was disclosed, Green Hongjing Bond A, while 143 public funds were not disclosed this quarter [2] Social Security and Pension Funds - One social security fund, the National Social Security Fund 111 Combination, reduced its holdings slightly [2] - One pension fund, the Basic Pension Insurance Fund 16032 Combination, increased its holdings by 0.5% [2]